|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||5.18 - 5.51|
|52 Week Range||2.61 - 10.91|
|Beta (5Y Monthly)||1.93|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Jul 14, 2008|
|1y Target Est||N/A|
KLM, the Dutch arm of Air France-KLM, on Friday said it would begin offering COVID-19 tested flights to Atlanta, the latest example of a European airline adopting a testing strategy to increase passenger confidence in flying amid the coronavirus pandemic. Under the KLM plan, passengers receive one test five days before their flight, another shortly before the flight, and a third after landing. "Only passengers with negative test results will be accepted on-board," KLM said in a statement.
KLM, the Dutch arm of Air France-KLM, said on Friday it would begin offering a "COVID-19 tested" flight from Atlanta to Amsterdam together with Delta four times a week from Dec. 15. Under the plan, passengers will be tested for the virus five days before departure. "Only passengers with negative test results will be accepted on-board," KLM said in a statement.
In cavernous cold-storage warehouses at Amsterdam's Schiphol Airport, KLM workers are gearing up for a surge next year in COVID-19 vaccine cargos that will need to be flown around the world at ultra-low temperatures. A major hub for pharmaceutical products, Schiphol has already handled some of the vaccines being used in trials and KLM's boss is confident its "cold chain" operations will cope with the influx of cargos as mass inoculations start in earnest. "The short and sweet of it is, yes, we're ready," KLM Chief Executive Pieter Elbers told Reuters.